Préfontaine Annick, Calderone Angelino, Dupuis Jocelyn
Research Centre, Montreal Heart Institute and Université de Montréal, Montreal, QC H1T1C8, Canada.
Can J Physiol Pharmacol. 2008 Jun;86(6):337-42. doi: 10.1139/Y08-024.
Proliferation of myofibroblasts (MYF) contributes to numerous lung disorders. Endothelin-1 (ET-1) production is increased in various lung diseases and could contribute to lung remodelling. The respective roles of ETA and ETB receptors (ETA-R, ETB-R) and the role of endogenous ET-1 production by lung MYF on proliferation of MYF remain uncertain. Rat lung MYF were isolated and 3H-thymidine and 3H-leucine incorporation assays were completed in the presence of a selective ETA-R antagonist, a selective ETB-R antagonist, or a combination of both. Receptor expression was evaluated by confocal imaging, and ET-1 levels were measured by ELISA. Confocal microscopy revealed abundant ETA-R and ETB-R expression on lung MYF. ET-1 (10 nmol/L) stimulated MYF proliferation and protein synthesis through PI3-kinase and p38 pathways. Although neither selective ETA-R blockade (BQ-123, 1 micromol/L) nor selective ETB-R blockade (BQ-788, 1 micromol/L) alone inhibited proliferation or protein synthesis, their combination almost completely abolished ET-1 mitogenic effect. Surprisingly, basal MYF proliferation was increased by selective blockade of either ETA-R or ETB-R alone, but not by dual blockade. ET-1 levels were not affected by the antagonists. Our findings indicate that both the ETA-R and the ETB-R regulate basal and stimulated lung MYF proliferation and suggest possible interactions between the receptors.
肌成纤维细胞(MYF)的增殖与多种肺部疾病有关。在各种肺部疾病中,内皮素-1(ET-1)的产生会增加,这可能导致肺部重塑。ETA和ETB受体(ETA-R、ETB-R)各自的作用以及肺MYF产生的内源性ET-1对MYF增殖的作用仍不明确。分离大鼠肺MYF,并在选择性ETA-R拮抗剂、选择性ETB-R拮抗剂或两者联合存在的情况下完成3H-胸腺嘧啶核苷和3H-亮氨酸掺入试验。通过共聚焦成像评估受体表达,并通过酶联免疫吸附测定法测量ET-1水平。共聚焦显微镜显示肺MYF上有丰富的ETA-R和ETB-R表达。ET-1(10 nmol/L)通过PI3激酶和p38途径刺激MYF增殖和蛋白质合成。虽然单独的选择性ETA-R阻断(BQ-123,1 μmol/L)或选择性ETB-R阻断(BQ-788,1 μmol/L)均未抑制增殖或蛋白质合成,但它们的联合几乎完全消除了ET-1的促有丝分裂作用。令人惊讶的是,单独选择性阻断ETA-R或ETB-R可增加基础MYF增殖,但双重阻断则不然。拮抗剂不影响ET-1水平。我们的研究结果表明,ETA-R和ETB-R均调节基础和刺激状态下的肺MYF增殖,并提示受体之间可能存在相互作用。